{"name":"Vasgene Therapeutics, Inc","slug":"vasgene-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxPTk1YUXBQN2tLdWY5RllZY29OTFVCcWNoSXNnOUR0eUhVdTJBYVRRbTNTcXlPYW5kMFl3Q0dGMHlmOXA4SWZvMmV0cXRieWwxNXlEM2NpVU5aYWFMSTQxSFV4OHRMLWlwZk9lblNJeHBuaWlIeW5PWDVXMzBZU3pLeVNERVB2NWlCNHpGQmljN0dMQVg4M2FGeTBpUnl2UjhqcGRmanhqNlV0RDFtQW5wWkJMaHFDQ3FyREVrTkV3aEV6c0ZEVHc5OU9peEliZk9KcC1TNXVJN3VXS1gxaFc3djk4VmgzUV80U1JMR1BKTExMN0dMMGNYVkphMTdQNUNRX0d2TTdDeEw2TkN0cjlyeE8yMmpBUFJhNERiWVRkbw?oc=5","date":"2026-02-26","type":"pipeline","source":"prnewswire.com","summary":"Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Strengthens | DelveInsight - prnewswire.com","headline":"Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Stre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQckpPUldMdjR0RTFmWjRtTWF0Mmtqc1ZoZklERVA2QzlQRk1nYlBPbmd4ZHN4SDdubElXSWhDS1Jzd0NzOFhuVEpvTjY1MzlzLWNVdV9XSE5kekFVMWV2TWxMYmZrdG5JYl9HS0dGZkpxV0JuSnJ2dUdoaDhlT3Z0Y25KbFR6aE9yb1ZzRHlDaUpTemUzM0dWMm5tX3Z5eGZjMnBKa19rMHRQaFRUWWNkMW9qS3laZTdJenBWYkxOVktoM1JFeUFrTnhWQ3NUQ0h4Z3ctdl9sai1qVjNqb2Exd1U1dlpnYkhkUzRjeS1lanVQSDVLQ2pxZE95V2tSc25Hcl9xWFU1VHFZaUhUUDM2RjR0Y19XNjVKMFFkVA?oc=5","date":"2025-11-27","type":"pipeline","source":"prnewswire.com","summary":"Rhabdomyosarcoma Market is Expected to Rise Throughout Forecast Period (2025-2034) with Promising Drug Candidates in Pipeline | DelveInsight - prnewswire.com","headline":"Rhabdomyosarcoma Market is Expected to Rise Throughout Forecast Period (2025-2034) with Promising Drug Candidates in Pip","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxPNjJBXzE5X0pwT3BfalJmLUZ4djRzczM5UEFnWldGSzl6Mkl3Rl81M09wODBaaFBmczNDNkxMWS1Ib05SeV9hUS0zLVZGc05LcnJHYk5OMk9MS3RGVDBKMVR1M1ZhRjdyMVdsbloxYzVnaTJiVlZaaDlfVThseFpSVDRnelUwLVUtUERIVEo5ZUV5b1daclQ2T2d0eFlkWWJaY2dSNWNIcWJsTmdvMDlzdUFacTZ5czczX19CX1dvbS13OV9wZ0lxOHBNWXYtc0RhWXNQNjlBdGpzaGZ4eklUQmNIX3Q3ZXN2ejczZzNlSHo4YWg5aVcyeDBYUjktdlE?oc=5","date":"2025-10-20","type":"pipeline","source":"prnewswire.com","summary":"Liposarcoma Market Set to Grow at a Steady CAGR by 2034 Amid Increasing Clinical Research Activities | DelveInsight - prnewswire.com","headline":"Liposarcoma Market Set to Grow at a Steady CAGR by 2034 Amid Increasing Clinical Research Activities | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxOYXM2QTdfbmJwVURFUnBPWXp0REUyblpQNXVXQ1NrY2IwVjdlQzFGaGhmcmZiclZoU0RBQzU0YV9UNmltUVRMX0ZHMEFhU3FzemVjQ1FrcmZ6YllSdmpqM3ROa19fQU1HTzc3SHBBQmFNYXgwaEdPZUNSX3I3RHd0N040MHRiSG95THF6M2FtMDhwQUxSNHhWQWpJNDZvdW9tLU5fT2k3UmQ2MC1kYXZ4ZkVPcC1lMlhHWlhWaEtKOG9HYjFTeFJvdzk2djd1RjVTQUR3LU1sclEwSzJiYUFBN3F3aG1tbXkzckFiT2xzV2VfQjJEY2tNRy02dEp3elFYQmg5Njk0ZThfMEs4eEhYaDhXMFRqVWd2VXdjMXZER0JQVXVVY0VrNGpn?oc=5","date":"2025-07-30","type":"pipeline","source":"prnewswire.com","summary":"Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight - prnewswire.com","headline":"Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technologi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPOTBsY2xKd1hGd1laU2Q4M3JiUUVRdVFqVGpOX19nYWF5T0ZEQ1JHRnVOOGJBTkRxQjNqMXpHMVUweXRXM2IzbGUxaWJIYVJVT0NYcjRXdG9IUl9tOHpIN01mMzlQcmhfbzU3Y2J4b1VEdjFmYVNiYW9PTHU5bnlRbTlPcEZZZXRDaS1XWDBtckgtMkcxQWlyVk9KaUJvbzJCbGxpZnc5cTQyek1DQks3V2M2N05lSFJrTVVzMmFxclU4b1VrTFo4Rm1FVjlfRGdnUUhqejI4V011MUJPSTVibA?oc=5","date":"2025-04-17","type":"pipeline","source":"prnewswire.com","summary":"FYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsight - prnewswire.com","headline":"FYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOalJtR2w0aVlVUFlGNlo5bEhmT1RxTmRmcm1FV1l0Z0dCQkVrSVN2aWo3dE1ERTBkR00zbzEwWUtGcjFiM2ZTc3NXeHBsbWZEYlU1Qk9QVXpvT21TMy10NlFiWnhXaTh5NXljeVJvalBmMkNBQXpfZzFUWHNJak1FLXlLZHptaGF2M2plZXQ3NjV3cjZLbmVhM3o1Q01CbXRiZFZQTm83Qlcyam93RnBJOFV4ZG9RU3cwZnJZTUhLejdNakZGbFZN?oc=5","date":"2024-10-01","type":"pipeline","source":"prnewswire.com","summary":"PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight - prnewswire.com","headline":"PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNTmtpYURaVEhPYkNqc0FkczdWaHNyQXpkVXRSaVRUT0RDTm42bDQ1N1d3eDh6ZXd6czdkVGdPak5IbGxaekROMEduQnJ2LUdzMFJpbTNyVlRuVDBQMmxHbFZFTlBOS3JvbkgwMVYxSEJnenNnU0dvaF9yUDMtTmxjcXVMeWRxX1hMZ3hTcXdVdFpGM0tUYjFmdHIxbDh4OE5iTVlBQ3Q4V2JyY0g1cWpnZmdzV21yMktObTJNMmY3X2FBQ2R0aXBKbEtOOElkdS1iSnd3SGNRWHNlYzdVT3VBTkh4cklVU0dsaWF2dlhmUnZKNmRBLUplLVhpSm8tODJnNVdHVWlxQUR3U1ZIRVFxYVdPczVMSXhxOGc?oc=5","date":"2023-05-10","type":"pipeline","source":"prnewswire.com","summary":"Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain | DelveInsight - prnewswire.com","headline":"Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}